(Q51943059)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639738%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Generalizability of cancer clinical trial results: prognostic differences between participants and nonparticipants (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639738%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639738%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

4

Michael Frumovitz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639738%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Linda S Elting

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639738%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Catherine Cooksley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639738%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

B Nebiyou Bekele

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639738%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Elenir B C Avritscher

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639738%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Charlotte Sun

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639738%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

English

0 references

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639738%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

number of pages

7

1 reference

inferred from page(s)

published in

Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639738%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639738%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639738%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

2452-2458

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639738%20AND%20SRC:MED&resulttype=core&format=json

Large-scale randomized evidence: large, simple trials and overviews of trials.

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21907

Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21907

Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect".

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21907

Selection bias in clinical trials of anaplastic glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21907

Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21907

Small-cell lung cancer: patients included in clinical trials are not representative of the patient population as a whole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21907

Improved survival and reduction in local failure rates after preoperative radiotherapy: evidence for the generalizability of the results of Swedish Rectal Cancer Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21907

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21907

Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21907

Socioeconomic status and cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21907

Long-term survival in Hodgkin's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21907

Randomized and non-randomized patients in clinical trials: experiences with comprehensive cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21907

Equipoise and the ethics of clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21907

7 January 2021

Nephroblastoma: treatment during 1970-3 and the effect on survival of inclusion in the first MRC trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21907

7 January 2021

Participants in prospective, randomized clinical trials for resected non-small cell lung cancer have improved survival compared with nonparticipants in such trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21907

7 January 2021

Patterns of care and survival for children with acute lymphoblastic leukaemia diagnosed between 1980 and 1994.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21907

7 January 2021

Leukemia in Rochester (NY). A 17-year experience with an analysis of the role of cooperative group (ECOG) participation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21907

7 January 2021

Protocol allocation and exclusion in two Danish randomised trials in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21907

7 January 2021

Impact of active and passive exclusions on the results of a clinical trial in multiple myeloma. The Myeloma Group of Western Sweden

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21907

7 January 2021

The selection of cases for randomised trials: a registry survey of concurrent trial and non-trial patients. The British Stomach Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21907

7 January 2021

Centralised treatment, entry to trials and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21907

7 January 2021